Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Tinzaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 4 Venous Thrombosis 2 Thromboembolism 2 Lung Neoplasms 2 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 57 Leucovorin 56 Oxaliplatin 38 Irinotecan 25 Folfox protocol 19 Capecitabine 18 Bevacizumab 17 Cetuximab 12 Chemotherapy, Adjuvant 11 Aspirin 6 Laparoscopy 5 Celecoxib 5 XELOX 4 dehydroftorafur 3 Panitumumab 3 Observation 3 Levamisole 3 Floxuridine 3 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Tegafur 2 Standard of Care 2 Octreotide 2 Occult Blood 2 Nivolumab 2 Neoadjuvant Therapy 2 Mitomycin 2 Immunoglobulin G 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01455831 2021-05-17

PERIOP-01

Ottawa Hospital Research Institute

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡